C
IRWD icon

Covestor’s Ironwood Pharmaceuticals IRWD Stock Holding History

Covestor’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1K Buy
317
+222
+234% +$856 ﹤0.01% 2203
2026
Q1 		$0 Buy
95
+1
+1% +$4 ﹤0.01% 2516
2025
Q4 		$0 Hold
94
– – ﹤0.01% 2491
2025
Q3 		$0 Hold
94
– – ﹤0.01% 2508
2025
Q2 		$0 Buy
94
+77
+453% +$60 ﹤0.01% 2461
2025
Q1 		$0 Hold
17
– – ﹤0.01% 2467
2024
Q4 		$0 Buy
17
+1
+6% +$4 ﹤0.01% 2476
2024
Q3 		$0 Buy
16
+6
+60% +$32 ﹤0.01% 2457
2024
Q2 		$0 Hold
10
– – ﹤0.01% 2476
2024
Q1 		$0 Sell
10
-4
-29% -$49 ﹤0.01% 2475
2023
Q4 		$0 Sell
14
-907
-98% -$8.97K ﹤0.01% 2399
2023
Q3 		$9K Buy
921
+71
+8% +$696 0.01% 1484
2023
Q2 		$9K Buy
850
+489
+135% +$5.26K 0.01% 1508
2023
Q1 		$4K Buy
361
+14
+4% +$157 ﹤0.01% 1608
2022
Q4 		$4K Sell
347
-108
-24% -$1.23K ﹤0.01% 1626
2022
Q3 		$5K Sell
455
-67
-13% -$760 ﹤0.01% 1493
2022
Q2 		$6K Sell
522
-28
-5% -$330 ﹤0.01% 1362
2022
Q1 		$7K Buy
550
+228
+71% +$2.61K ﹤0.01% 1408
2021
Q4 		$4K Buy
+322
New +$3.95K 0.01% 1396

Other funds holding IRWD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $178M AUM 118.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Covestor's IRWD Position: Q2 2026 in Review

Covestor increased its Ironwood Pharmaceuticals (IRWD) stake by 234% in Q2 2026, buying an estimated $856 and bringing the position to 317 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #2203.

Covestor first reported a position in IRWD in Q4 2021 and has held it in 19 quarters since. The position peaked at $9K in Q3 2023. 212 funds tracked by Wall St. Rank hold IRWD as of Q2 2026.

  • Covestor held 317 shares of Ironwood Pharmaceuticals worth $1K as of Q2 2026.
  • Covestor bought 222 Ironwood Pharmaceuticals shares in Q2 2026, an estimated $856.
  • Ironwood Pharmaceuticals made up ﹤0.01% of Covestor's portfolio in Q2 2026, its #2203 holding.
  • Covestor first reported a position in Ironwood Pharmaceuticals in Q4 2021 and has held it in 19 quarters since.
  • Covestor's Ironwood Pharmaceuticals position peaked at $9K in Q3 2023.
  • 212 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q2 2026.

Based on Covestor's 13F filing for Q2 2026, filed 7 Aug 2026.